Displaying 3381 - 3400 of 4733
FTC Seeks Public Comments on Dow Chemical Company's Application to Approve Amendments to Asset Purchase Agreement with Arkema Inc.
Irving Oil Limited and Irving Oil Terminals Inc., In the Matter of
The Commission required Irving Oil Terminals Inc. and Irving Oil Limited to relinquish the rights to terminal and pipeline assets in Maine that Irving acquired from ExxonMobil, to maintain competition in gasoline and distillates terminaling services in the South Portland and Bangor/Penobscot Bay areas. The proposed settlement resolves the FTC’s charges that the acquisition is anticompetitive and could result in higher gasoline and diesel prices for consumers.
Southwest Health Alliances, Inc.
An association representing 900 physicians in the Amarillo, Texas, area agreed to a Commission order barring it from jointly negotiating the prices it charges insurance providers. The FTC alleged in a complaint filed with the order that the association, Southwest Health Alliances, Inc., d/b/a BSA Provider Network, has violated federal law since 2000 by fixing the prices its member doctors would charge insurers. The Commission's order requires the association to cease and desist.
FTC, DOJ Announce Changes to Streamline the Premerger Notification Form
FTC Approves Tops Markets' Application to Divest Three Former Penn Traffic Supermarkets in New York and Pennsylvania, Finalizes Modified Settlement Order
FTC Extends Deadline to Comment on Patents and Standard-Setting Project
FTC Approves Simon Property Group's Request to Divest Prime Outlets in Jeffersonville, Ohio, to Tanger Properties Limited Partnership
Simon Property Group, Inc., In the Matter of
Under the terms of the settlement, Simon Property Group, Inc. is required to divest property and modify tenant leases to preserve outlet center competition in parts of southwest Ohio, Chicago, Illinois, and Orlando, Florida, in the wake of Simon’s purchase of Prime Outlets Acquisition Company, LLC. In addition, Simon has agreed to remove radius restrictions for tenants with stores in its outlet malls serving the Chicago and Orlando markets.
FTC Seeks Public Comment on ConocoPhillips' Application to Modify Final Commission Order and to Approve Amended Licensing Agreements with Holly Corp.
Tools to Prevent Patent "Hold-up": IP Rights in Standard Setting
1106003 Informal Interpretation
FTC Denies Dow Chemical's Application to Modify its 2009 Consent Order Requiring Sale of Chemicals Facility in California
1106003 Informal Interpretation
FTC Staff Says Proposed Connecticut Legislation Would Likely Increase Health Care Costs and Decrease Access to Care
Hikma Pharmaceuticals PLC, In the Matter of (Baxter)
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’s entire generic injectable pharmaceutical business for $111.5 million, including Baxter’s Cherry Hill, New Jersey, manufacturing facility and a warehouse and distribution center in Memphis, Tennessee. Phenytoin is an anti-convulsant drug used to control and prevent seizures during or after surgery and Promethazine is used to prevent some types of allergies or allergic reactions, to prevent or control motion sickness, nausea, vomiting, and dizziness, and to help patients go to sleep and control their pain or anxiety before or after surgery.
FTC Approves Universal Health Services' and Psychiatric Solutions' Application to Sell the Delaware Behavioral Health Assets
FTC Approves Final Order Settling Charges that Hikma Pharmaceuticals PLC's Acquisition of Baxter Healthcare Assets was Anticompetitive
FTC Staff Submits Comment to FERC on Assessing the Effects of Proposed Horizontal Mergers on Market Power
FTC Issues Agenda for Workshop to Explore the Role of Patented Technology in Collaborative Industry Standards
Displaying 3381 - 3400 of 4733